Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
28.54
+0.66 (2.37%)
At close: Nov 6, 2026, 4:00 PM EST
28.53
-0.01 (-0.04%)
After-hours: Nov 6, 2026, 7:30 PM EST
Parabilis Medicines Employees
Parabilis Medicines had 145 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025. That makes Parabilis Medicines the 29,077th largest employer in the world and 3,699th in the United States.
Employees
145
Change
n/a
Growth
n/a
Revenue / Employee
$1,021
Profits / Employee
-$1,597,703
Market Cap
3.53B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 145 | 0 | - |
| Dec 31, 2025 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| Tarsus Pharmaceuticals | 370 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 289 |
| Disc Medicine | 165 |
PBLS News
- 3 days ago - Parabilis Medicines to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 12 days ago - Parabilis Medicines announces safety, efficacy data for zolucatetide - TheFly
- 13 days ago - Parabilis Medicines Transcript: Investor update - Transcripts
- 13 days ago - Parabilis Medicines Slides: Investor update - Filings
- 13 days ago - Parabilis Medicines Press release: Investor update - Filings
- 13 days ago - Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors - GlobeNewsWire
- 15 days ago - Parabilis Medicines initiated with a Buy at H.C. Wainwright - TheFly
- 18 days ago - Why Is Parabilis Medicines Stock (PBLS) Up 11% Today? - TipRanks